NCAM1 and neoplasm: Instead, soluble inhibitory factors released by tumor cells or tumor-infiltrating immune cells might mediate such functional impairment of CD3+CD56+ NKT-like cells, for we observed that tumor tissue culture supernatant from GC patients impaired the effector function of CD3+CD56+ NKT-like cells.